HIQBIOT
Index Performance
-3.93%
HIQBIOT
+4.60%
TMLARGE
+1.34%
DIA
Overview
Description
Biotech
- TickerHIQBIOT
- Inception Date12/03/2023
- WeightingSq. Root Market Cap
- # of holdings147
What's inside?
Holdings
All holdings as of May 3, 2024
CSV download
| Amgen, Inc. (AMGN) | 4.17% | $166.83B | 22.19% | 56.73% | 7.04 |
| Danaher Corp. (DHR) | 3.91% | $183.97B | -19.13% | 60.16% | 7.59 |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2.97% | $103.71B | -0.54% | 82.58% | 7.86 |
| Vertex Pharmaceuticals, Inc. (VRTX) | 2.93% | $103.60B | 12.47% | 87.17% | 9.71 |
| CSL Ltd. (CSL) | 2.77% | $87.71B | 35.36% | 48.33% | 7.83 |
| Gilead Sciences, Inc. (GILD) | 2.52% | $80.78B | 5.66% | 76.79% | N/A |
| Moderna, Inc. (MRNA) | 2.29% | $47.90B | -91.07% | 20.96% | 6.49 |
| Lonza Group AG (LONN) | 2.00% | $42.51B | 7.94% | 27.04% | 4.11 |
| IQVIA Holdings, Inc. (IQV) | 1.76% | $40.70B | 2.89% | 27.59% | 3.90 |
| Biogen, Inc. (BIIB) | 1.63% | $31.67B | -5.62% | 68.65% | 4.02 |
| Novozymes A/S (NZYM.B) | 1.45% | $16.47B | 1.97% | 52.03% | 6.15 |
| BioNTech SE (BNTX) | 1.43% | $22.04B | -77.31% | 85.01% | 3.14 |
| ICON plc (ICLR) | 1.41% | $25.55B | 5.65% | 22.48% | 3.79 |
| argenx SE (ARGX) | 1.40% | $22.90B | 198.86% | 81.59% | 15.14 |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 1.30% | $19.27B | 54.82% | 86.65% | 9.57 |
| BeiGene Ltd. (688235) | 1.26% | $17.68B | 82.71% | 81.13% | 9.91 |
| Sartorius Stedim Biotech SA (DIM) | 1.25% | $21.78B | -6.86% | N/A | N/A |
| Avantor, Inc. (AVTR) | 1.19% | $16.79B | -5.65% | 33.96% | 3.28 |
| Sandoz Group AG (SDZ) | 1.15% | $13.67B | 0.74% | N/A | N/A |
| Neurocrine Biosciences, Inc. (NBIX) | 1.12% | $14.16B | 22.57% | 97.52% | 6.87 |
| United Therapeutics Corp. (UTHR) | 1.11% | $11.64B | 33.70% | 89.24% | 3.73 |
| Sarepta Therapeutics, Inc. (SRPT) | 1.10% | $12.63B | 63.10% | 85.66% | 9.14 |
| Bio-Techne Corp. (TECH) | 1.03% | $12.15B | 3.16% | 73.79% | 10.09 |
| bioMérieux SA (BIM) | 1.01% | $12.54B | 2.38% | 54.87% | 3.30 |
| WuXi AppTec Co., Ltd. (603259) | 0.99% | $16.96B | 2.27% | 39.99% | 5.18 |
| Charles River Laboratories International, Inc. (CRL) | 0.97% | $11.99B | 3.86% | 33.70% | 3.65 |
| Incyte Corp. (INCY) | 0.96% | $12.07B | 8.93% | 91.24% | 2.42 |
| ImmunityBio, Inc. (IBRX) | 0.94% | $6.19B | 159.17% | -2,876.21% | 5,099.06 |
| Catalent, Inc. (CTLT) | 0.93% | $10.23B | -10.88% | 16.70% | 3.15 |
| Roivant Sciences Ltd. (ROIV) | 0.90% | $9.18B | 117.80% | 82.20% | 30.90 |
| Revolution Medicines, Inc. (RVMD) | 0.88% | $6.85B | -67.27% | 19.61% | 127.82 |
| Imeik Technology Development Co., Ltd. (300896) | 0.85% | $8.99B | 28.12% | 94.52% | 23.21 |
| Kyowa Kirin Co., Ltd. (4151) | 0.85% | $9.36B | 11.01% | 72.50% | 2.02 |
| Blueprint Medicines Corp. (BPMC) | 0.83% | $6.71B | 51.87% | 91.68% | 21.27 |
| Ascendis Pharma A/S (ASND) | 0.80% | $7.92B | 436.15% | 78.07% | 25.52 |
| Bruker Corp. (BRKR) | 0.79% | $9.64B | 5.31% | 48.66% | 4.92 |
| Intra-Cellular Therapies, Inc. (ITCI) | 0.79% | $7.26B | 85.51% | 92.73% | 13.75 |
| Cytokinetics, Inc. (CYTK) | 0.78% | $6.83B | -92.04% | -57.93% | 1,088.89 |
| Grifols SA (GRF) | 0.78% | $5.71B | 8.71% | 35.24% | 3.37 |
| Beijing Tiantan Biological Products Corp. Ltd. (600161) | 0.76% | $6.55B | -5.56% | 55.63% | 8.49 |
| Vaxcyte, Inc. (PCVX) | 0.75% | $7.17B | N/A | N/A | N/A |
| Shanghai RAAS Blood Products Co., Ltd. (002252) | 0.74% | $6.59B | -0.51% | 39.26% | 5.30 |
| Exelixis, Inc. (EXEL) | 0.74% | $6.38B | 4.02% | 95.00% | 3.51 |
| Changchun High-Tech Industry (Group) Co., Ltd. (000661) | 0.71% | $6.32B | 14.51% | 83.30% | 3.06 |
| Akeso, Inc. (9926) | 0.68% | $5.43B | 401.75% | 93.91% | 7.31 |
| DiaSorin SpA (DIA) | 0.67% | $5.41B | -15.64% | 58.27% | 5.21 |
| Halozyme Therapeutics, Inc. (HALO) | 0.65% | $5.07B | 25.62% | 67.91% | 7.42 |
| SK Biopharmaceuticals Co., Ltd. (326030) | 0.64% | $4.98B | 44.16% | 86.89% | 22.08 |
| BridgeBio Pharma, Inc. (BBIO) | 0.63% | $5.21B | 11,461.88% | 99.10% | 30.87 |
| Wuxi Biologics (Cayman), Inc. (2269) | 0.63% | $7.61B | 6.01% | 40.08% | 6.66 |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 0.61% | $4.89B | N/A | N/A | N/A |
| Chongqing Zhifei Biological Products Co., Ltd. (300122) | 0.61% | $6.89B | 2.00% | 25.72% | 2.08 |
| Tecan Group AG (TECN) | 0.60% | $4.61B | -6.11% | 33.40% | 4.05 |
| Apellis Pharmaceuticals, Inc. (APLS) | 0.60% | $5.72B | 425.83% | 84.82% | 17.30 |
| Hualan Biological Engineering, Inc. (002007) | 0.59% | $4.23B | -10.41% | 55.20% | 6.85 |
| Crinetics Pharmaceuticals, Inc. (CRNX) | 0.57% | $3.68B | -15.28% | 72.64% | 388.57 |
| Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262) | 0.56% | $3.48B | 15.22% | 70.37% | 3.70 |
| Axsome Therapeutics, Inc. (AXSM) | 0.55% | $3.54B | 440.80% | 87.84% | 12.62 |
| Immunovant, Inc. (IMVT) | 0.55% | $4.19B | N/A | N/A | N/A |
| RemeGen Co., Ltd. (688331) | 0.55% | $3.43B | 96.12% | 77.19% | 24.34 |
| Nuvalent, Inc. (NUVL) | 0.55% | $4.12B | N/A | N/A | N/A |
| Fortrea Holdings, Inc. (FTRE) | 0.55% | $3.34B | 0.42% | 13.64% | 1.50 |
| Insmed, Inc. (INSM) | 0.54% | $3.79B | 24.39% | 76.86% | 16.17 |
| Shanghai Junshi Biosciences Co., Ltd. (688180) | 0.53% | $3.54B | 49.13% | 71.19% | 15.80 |
| Alkermes Plc (ALKS) | 0.53% | $4.07B | 21.83% | 82.56% | 2.50 |
| Xenon Pharmaceuticals, Inc. (XENE) | 0.52% | $3.30B | -100.00% | N/A | N/A |
| Lepu Medical Technology (Beijing) Co., Ltd. (300003) | 0.52% | $3.27B | -21.33% | 66.46% | 3.82 |
| Springworks Therapeutics, Inc. (SWTX) | 0.51% | $3.34B | N/A | 90.81% | 121.00 |
| Iovance Biotherapeutics, Inc. (IOVA) | 0.51% | $3.81B | N/A | -2,686.12% | 1,436.18 |
| Sinopharm Group Co., Ltd. (1099) | 0.50% | $3.36B | 2.67% | 7.83% | 0.23 |
| Asymchem Laboratories (Tianjin) Co., Ltd. (002821) | 0.50% | $4.09B | -39.35% | 41.82% | 3.35 |
| Olink Holding AB (OLK) | 0.49% | $2.86B | 21.60% | 58.19% | 17.80 |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 0.49% | $2.63B | 227.56% | 86.82% | 32.07 |
| Merus NV (MRUS) | 0.49% | $2.80B | 5.68% | N/A | 24.49 |
| PTC Therapeutics, Inc. (PTCT) | 0.49% | $2.53B | -4.66% | 68.46% | 1.90 |
| IDEAYA Biosciences, Inc. (IDYA) | 0.49% | $3.15B | -54.08% | 82.86% | 65.18 |
| MorphoSys AG (MOR) | 0.48% | $2.69B | -55.81% | 85.96% | 10.61 |
| Twist Bioscience Corp. (TWST) | 0.47% | $2.40B | 25.13% | 41.01% | 6.41 |
| 3SBio, Inc. (1530) | 0.47% | $2.12B | 8.27% | 84.98% | 2.27 |
| Tonghua Dongbao Pharmaceutical Co., Ltd. (600867) | 0.47% | $2.71B | -11.15% | 78.55% | 6.47 |
| Certara, Inc. (CERT) | 0.47% | $2.81B | 5.57% | 47.35% | 8.07 |
| Elekta AB (EKTA.B) | 0.47% | $2.60B | 4.61% | 36.65% | 1.91 |
| Walvax Biotechnology Co., Ltd. (300142) | 0.46% | $3.19B | -27.51% | 80.94% | 6.07 |
| Vericel Corp. (VCEL) | 0.46% | $2.31B | 20.17% | 68.64% | 8.38 |
| Vera Therapeutics, Inc. (VERA) | 0.45% | $2.39B | N/A | N/A | N/A |
| Amicus Therapeutics, Inc. (FOLD) | 0.45% | $3.08B | 21.30% | 88.68% | 10.89 |
| Peptidream, Inc. (4587) | 0.44% | $1.69B | 6.93% | 58.73% | 6.84 |
| Betta Pharmaceuticals Co., Ltd. (300558) | 0.43% | $2.41B | 38.45% | 82.41% | 7.24 |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 0.43% | $3.03B | -94.32% | -20.05% | 19.11 |
| Arcellx, Inc. (ACLX) | 0.43% | $2.81B | N/A | 98.15% | 18.68 |
| Biohaven Ltd. (BHVN) | 0.42% | $3.56B | N/A | N/A | N/A |
| Agios Pharmaceuticals, Inc. (AGIO) | 0.42% | $1.96B | 46.00% | 75.88% | 38.06 |
| Kymera Therapeutics, Inc. (KYMR) | 0.42% | $2.29B | 8.67% | 85.42% | 30.37 |
| ACADIA Pharmaceuticals, Inc. (ACAD) | 0.42% | $2.82B | 40.45% | 93.70% | 6.54 |
| Denali Therapeutics, Inc. (DNLI) | 0.41% | $2.44B | 204.74% | 94.94% | 5.95 |
| Shenzhen Kangtai Biological Products Co., Ltd. (300601) | 0.41% | $2.41B | -39.68% | 83.97% | 8.29 |
| Keros Therapeutics, Inc. (KROS) | 0.40% | $2.18B | N/A | -439.74% | 5,656.39 |
| Rocket Pharmaceuticals, Inc. (RCKT) | 0.40% | $2.13B | N/A | N/A | N/A |
| Bavarian Nordic A/S (BAVA) | 0.40% | $1.75B | 123.99% | 64.07% | 1.68 |
| Syndax Pharmaceuticals, Inc. (SNDX) | 0.39% | $1.87B | N/A | N/A | N/A |
| Neuren Pharmaceuticals Ltd. (NEU) | 0.38% | $1.68B | 1,493.66% | N/A | 13.09 |
| Structure Therapeutics, Inc. (GPCR) | 0.37% | $1.83B | N/A | N/A | N/A |
| Taro Pharmaceutical Industries Ltd. (TARO) | 0.37% | $1.60B | 12.89% | 50.85% | 1.09 |
| Arvinas, Inc. (ARVN) | 0.37% | $2.24B | -40.26% | 91.46% | 13.01 |
| Galapagos NV (GLPG) | 0.37% | $1.91B | -65.10% | 95.92% | -6.68 |
| Bio-Thera Solutions, Ltd. (688177) | 0.36% | $1.89B | 4.39% | 69.69% | 21.16 |
| Kura Oncology, Inc. (KURA) | 0.36% | $1.57B | N/A | N/A | N/A |
| Jinyu Bio-Technology Co., Ltd. (600201) | 0.36% | $1.41B | -4.45% | 60.48% | 5.17 |
| Xencor, Inc. (XNCR) | 0.36% | $1.49B | 2.28% | 93.17% | 4.60 |
| Dynavax Technologies Corp. (DVAX) | 0.35% | $1.53B | -67.86% | 78.40% | 5.66 |
| Evotec SE (EVT) | 0.35% | $1.86B | 3.99% | 22.40% | 4.85 |
| Recursion Pharmaceuticals, Inc. (RXRX) | 0.34% | $2.03B | 11.88% | -14.61% | 38.26 |
| Vir Biotechnology, Inc. (VIR) | 0.34% | $1.41B | -10.45% | 91.88% | 4.13 |
| Protagonist Therapeutics, Inc. (PTGX) | 0.33% | $1.52B | 125.73% | 94.48% | 16.02 |
| Zai Lab Ltd. (9688) | 0.33% | $1.62B | 24.01% | 64.08% | 6.99 |
| Morphic Holding, Inc. (MORF) | 0.33% | $1.66B | -100.00% | N/A | N/A |
| CanSino Biologics, Inc. (CASBF) | 0.32% | $844.26M | 8.16% | 58.84% | 4.68 |
| BioArctic AB (BRCTF) | 0.32% | $1.31B | 169.83% | 56.22% | 36.67 |
| Chengdu Kanghua Biological Products Co., Ltd. (300841) | 0.31% | $1.17B | 11.90% | 95.83% | 4.11 |
| Ironwood Pharmaceuticals, Inc. (IRWD) | 0.30% | $1.29B | 7.83% | 99.64% | 5.42 |
| Simulations Plus, Inc. (SLP) | 0.30% | $933.30M | 16.22% | 72.23% | 11.38 |
| MiMedx Group, Inc. (MDXG) | 0.29% | $1.09B | 18.18% | 84.45% | 3.37 |
| Prothena Corp. Plc (PRTA) | 0.29% | $1.23B | 69.50% | 90.79% | 14.51 |
| GH Research Plc (GHRS) | 0.28% | $607.69M | N/A | N/A | N/A |
| CureVac NV (CVAC) | 0.24% | $700.75M | -17.98% | -172.97% | 9.14 |
| Mind Medicine (MindMed), Inc. (MNMD) | 0.24% | $705.01M | N/A | N/A | N/A |
| Novavax, Inc. (NVAX) | 0.23% | $692.18M | -50.36% | 71.59% | 0.19 |
| SAGE Therapeutics, Inc. (SAGE) | 0.22% | $838.94M | 139.89% | 83.94% | 4.52 |
| Adaptive Biotechnologies Corp. (ADPT) | 0.17% | $443.58M | -8.11% | 42.57% | 3.47 |
| Annexon, Inc. (ANNX) | 0.17% | $444.77M | N/A | N/A | N/A |
| Organogenesis Holdings, Inc. (ORGO) | 0.16% | $330.11M | -3.94% | 71.52% | 1.29 |
| Emergent BioSolutions, Inc. (EBS) | 0.15% | $203.84M | 81.95% | 46.40% | 0.82 |
| Revance Therapeutics, Inc. (RVNC) | 0.15% | $411.65M | 76.55% | 62.38% | 4.13 |
| Adaptimmune Therapeutics Plc (ADAP) | 0.14% | $304.12M | 123.04% | 83.71% | 0.62 |
| CStone Pharmaceuticals Co. Ltd. (2616) | 0.14% | $177.53M | -8.44% | 61.50% | 4.17 |
| Acumen Pharmaceuticals, Inc. (ABOS) | 0.12% | $209.68M | N/A | N/A | N/A |
| VistaGen Therapeutics, Inc. (VTGN) | 0.10% | $121.61M | 129.06% | 65.19% | 25.66 |
| Leap Therapeutics, Inc. (LPTX) | 0.09% | $122.06M | N/A | N/A | N/A |
| JW (Cayman) Therapeutics Co. Ltd. (2126) | 0.09% | $101.49M | 13.38% | 7.69% | 0.90 |
| Relmada Therapeutics, Inc. (RLMD) | 0.08% | $111.04M | N/A | N/A | N/A |
| FibroGen, Inc. (FGEN) | 0.07% | $113.40M | 4.99% | 87.24% | 0.43 |
| NanoString Technologies, Inc. (NSTG) | 0.03% | $9.86M | 62.79% | 36.19% | 1.43 |
| FSD Pharma, Inc. (HUGE) | 0.02% | $15.39M | N/A | N/A | N/A |
| NRX Pharmaceuticals, Inc. (NRXP) | 0.02% | $22.17M | N/A | N/A | N/A |
| Bright Minds Biosciences, Inc. (DRUG) | 0.01% | $4.33M | N/A | N/A | N/A |
| Enveric Biosciences, Inc. (ENVB) | 0.01% | $7.15M | N/A | N/A | N/A |
| Seelos Therapeutics, Inc. (SEEL) | 0.01% | $5.64M | N/A | 97.41% | 8.19 |
Market data by FactSet
